ChatGPT and generative AI in urology and surgery—A narrative review

Abstract

IntroductionChatGPT (generative pre‐trained transformer [GPT]), developed by OpenAI, is a type of generative artificial intelligence (AI) that has been widely utilised since its public release. It orchestrates an advanced conversational intelligence, producing sophisticated responses to questions. ChatGPT has been successfully demonstrated across several applications in healthcare, including patient management, academic research and clinical trials. We aim to evaluate the different ways ChatGPT has been utilised in urology and more broadly in surgery.MethodsWe conducted a literature search of the PubMed and Embase electronic databases for the purpose of writing a narrative review and identified relevant articles on ChatGPT in surgery from the years 2000 to 2023. A PRISMA flow chart was created to highlight the article selection process. The search terms ‘ChatGPT’ and ‘surgery’ were intentionally kept broad given the nascency of the field. Studies unrelated to these terms were excluded. Duplicates were removed.ResultsMultiple papers have been published about novel uses of ChatGPT in surgery, ranging from assisting in administrative tasks including answering frequently asked questions, surgical consent, writing operation reports, discharge summaries, grants, journal article drafts, reviewing journal articles and medical education. AI and machine learning has also been extensively researched in surgery with respect to patient diagnosis and predicting outcomes. There are also several limitations with the software including artificial hallucination, bias, out‐of‐date information and patient confidentiality.ConclusionThe potential of ChatGPT and related generative AI models are vast, heralding the beginning of a new era where AI may eventually become integrated seamlessly into surgical practice. Concerns with this new technology must not be disregarded in the urge to hasten progression, and potential risks impacting patients' interests must be considered. Appropriate regulation and governance of this technology will be key to optimising the benefits and addressing the intricate challenges of healthcare delivery and equity.